ProShares Nanotechnology Valuation
| TINY Etf | USD 49.30 0.67 1.38% |
At this time, the etf appears to be fairly valued. ProShares Nanotechnology holds a recent Real Value of $48.62 per share. The prevailing price of the etf is $49.3. Our model determines the value of ProShares Nanotechnology from analyzing the etf fundamentals such as Current Valuation of 51.56 M, return on asset of -0.03, and Shares Owned By Insiders of 7.58 % as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that ProShares Nanotechnology's price fluctuation is very steady at this time. Calculation of the real value of ProShares Nanotechnology is based on 3 months time horizon. Increasing ProShares Nanotechnology's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since ProShares Nanotechnology is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ProShares Etf. However, ProShares Nanotechnology's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 49.3 | Real 48.62 | Hype 49.3 | Naive 50.18 |
The intrinsic value of ProShares Nanotechnology's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence ProShares Nanotechnology's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of ProShares Nanotechnology ETF helps investors to forecast how ProShares etf's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ProShares Nanotechnology more accurately as focusing exclusively on ProShares Nanotechnology's fundamentals will not take into account other important factors: ProShares Nanotechnology Total Value Analysis
ProShares Nanotechnology ETF is at this time estimated to have valuation of 51.56 M with market capitalization of 40.18 M, debt of 5 M, and cash on hands of 17.92 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the ProShares Nanotechnology fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
51.56 M | 40.18 M | 5 M | 17.92 M |
ProShares Nanotechnology Investor Information
ProShares Nanotechnology is is formed as Regulated Investment Company in the United States. ETF is managed and operated by J.P. Morgan Chase Bank, N.A.. The fund has 31 constituents across multiple sectors and instustries. The fund charges 0.58 percent management fee with a total expences of 0.58 percent of total asset. The fund maintains 99.7% of assets in stocks. Based on the key measurements obtained from ProShares Nanotechnology's financial statements, ProShares Nanotechnology ETF is not in a good financial situation at the present time. It has a very high likelihood of going through financial trouble in February.ProShares Nanotechnology Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. ProShares Nanotechnology has an asset utilization ratio of 47.76 percent. This suggests that the ETF is making $0.48 for each dollar of assets. An increasing asset utilization means that ProShares Nanotechnology ETF is more efficient with each dollar of assets it utilizes for everyday operations.ProShares Nanotechnology Ownership Allocation
ProShares Nanotechnology owns a total of 31.17 Million outstanding shares. 30% of ProShares Nanotechnology ETF outstanding shares are owned by third-party entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company maintains, if the real value of the etf is less than the current market value, you may not be able to make money on it.ProShares Nanotechnology Profitability Analysis
The company reported the previous year's revenue of 917 K. Net Loss for the year was (20.25 M) with profit before overhead, payroll, taxes, and interest of 917 K.About ProShares Nanotechnology Valuation
Our relative valuation model uses a comparative analysis of ProShares Nanotechnology. We calculate exposure to ProShares Nanotechnology's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of ProShares Nanotechnology's related companies.The index consists of companies focused on making or applying nanotechnology innovations that allow for improved products, processes, or techniques through control or measurement of material at nanoscale. Proshares Nanotechnology is traded on NYSEARCA Exchange in the United States.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in ProShares Nanotechnology ETF. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
The market value of ProShares Nanotechnology is measured differently than its book value, which is the value of ProShares that is recorded on the company's balance sheet. Investors also form their own opinion of ProShares Nanotechnology's value that differs from its market value or its book value, called intrinsic value, which is ProShares Nanotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProShares Nanotechnology's market value can be influenced by many factors that don't directly affect ProShares Nanotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProShares Nanotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if ProShares Nanotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProShares Nanotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.